ADVERTISEMENT
Videos
Dr Diehl Talks NGS, ctDNA Monitoring, and Organoid Screening in Ongoing BTC Trial
01/26/2021
Adam Diehl, MD, Fred Hutchinson Cancer Research Center, discusses an ongoing clinical trial assessing the ability to obtain NGS, ctDNA monitoring, and organoid drug sensitivity screening in patients with resected localized biliary tract cancer. These data were presented at the 2021 ASCO GI Cancer Symposium.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement